LYRA icon

Lyra Therapeutics
LYRA

Overview Fund Trends Analyst Outlook Journalist POV

31 hedge funds and large institutions have $38.1M invested in Lyra Therapeutics in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

36% less capital invested

Capital invested by funds: $59.9M → $38.1M (-$21.8M)

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

Holders
31
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$9K
Puts
$1K
Net Calls
Net Calls Change

Top Buyers

1
+$120K
2
+$23.4K
3
+$21.4K
4
TRCT
Tower Research Capital (TRC)
New York
+$10.4K
5
Bank of America
Bank of America
North Carolina
+$6.03K

Top Sellers

1
-$322K
2
-$123K
3
-$42.6K
4
Citadel Advisors
Citadel Advisors
Florida
-$35.8K
5
BAM
Belpointe Asset Management
Nevada
-$11.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$1.31K
27
$1K
28
$1K
29
$1K
30
$229
31
–
32
–
33
–
34
–
35
–
36
–
37
–
1
2